0
ARTICLE |

CLINICAL USE OF FAT INJECTED INTRAVENOUSLY

THEODORE B. VAN ITALLIE, M.D.; WILLIAM R. WADDELL, M.D.; ROBERT P. GEYER, Ph.D.; FREDRICK J. STARE, Ph.D., M.D.
AMA Arch Intern Med. 1952;89(3):353-357. doi:10.1001/archinte.1952.00240030002001.
Text Size: A A A
Published online

A MAJOR problem in parenteral feeding is associated with the need for a nonsclerosing preparation for intravenous administration which contains a large supply of calories in a small volume of fluid. Fat emulsions appear to offer a solution to this problem. Fat particles do not exert an osmotic effect; accordingly, fat may be injected in high concentrations without damage to veins and in a relatively small fluid volume. Unlike dextrose and amino acids, fat is not excreted in the urine in significant amounts.

Among the earliest clinical studies involving the intravenous administration of fat emulsions for caloric purposes was one reported by Yamakawa in Japan in 1920.1 Later, in this country, Holt, Tidwell, and Scott2 studied the effect of intravenous fat administration in experimental animals and in children.

In the interim, although fat emulsions for intravenous administration still have not become available commercially, their use in man is

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs